Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Exosomes vs PRP in Androgenetic Alopecia
NCT06239207Phase 2Completed
- Sponsor
- Services Hospital Lahore
- Start
- Sep 2023
- Primary completion
- Jul 2024
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial in androgenetic alopecia (AGA), sponsored by Services Hospital Lahore. Primary endpoint: Increase in hair density at 6 months. Started Sep 2023; status: completed.
02
Conditions
androgenetic alopecia (AGA)
Beyond the preview
Go deeper on NCT06239207.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06239207.